Qin Huo1, Zhenwei Li1, Siqi Chen1, Juan Wang2, Jiaying Li2, Ni Xie3. 1. Biobank, Shenzhen Institute of Translational Medicine, Shenzhen Second People's Hospital, First Affiliated Hospital of Shenzhen University , Shenzhen, 518035, China. 2. Department of Clinical Medicine , University of South China , Hengyang , 421001 , China. 3. Biobank, Shenzhen Institute of Translational Medicine, Shenzhen Second People's Hospital, First Affiliated Hospital of Shenzhen University , Shenzhen, 518035, China. xn100@szu.edu.cn.
Abstract
PURPOSE: Von Willebrand Factor C and EGF Domains (VWCE) is an important gene that regulates cell adhesion, migration, and interaction. However, the correlation between VWCE expression and immune infiltrating in breast cancer remain unclear. In this study, we investigated the correlation between VWCE expression and immune infiltration levels in breast cancer. METHODS: The expression of VWCE was analyzed by the tumor immune estimation resource (TIMER) and DriverDB databases. Furthermore, genes co-expressed with VWCE and gene ontology (GO) enrichment analysis were investigated by the STRING and Enrichr web servers. Also, we performed the single nucleotide variation (SNV), copy number variation (CNV), and pathway activity analysis through GSCALite. Subsequently, the relationship between VWCE expression and tumor immunity was analyzed by TIMER and TISIDB databases, and further verified the results using Quantitative Real-Time PCR (RT-PCR), Western blotting, and immunohistochemistry. RESULTS: The results showed that the expression of VWCE mRNA in breast cancer tissue was significantly lower than that in normal tissues. We found that the expression level of VWCE was associated with subtypes, estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor-2 (HER2) status of breast cancer patients, but there was no significant difference in the expression of VWCE was found in age and nodal status. Further analyses indicated that VWCE was correlated with the activation or inhibition of multiple oncogenic pathways. Additionally, VWCE expression was negatively correlated with the expression of STAT1 (Th1 marker, r = - 0.12, p = 6e-05), but positively correlated with the expression of MS4A4A (r = 0.28, p = 0). These results suggested that the expression of VWCE was correlated with immune infiltration levels of Th1 and M2 macrophage in breast cancer. CONCLUSIONS: In our study, VWCE expression was associated with a better prognosis and was immune infiltration in breast cancer. These findings demonstrate that VWCE is a potential prognostic biomarker and correlated with tumor immune cell infiltration, and maybe a promising therapeutic target in breast cancer.
PURPOSE:Von Willebrand Factor C and EGF Domains (VWCE) is an important gene that regulates cell adhesion, migration, and interaction. However, the correlation between VWCE expression and immune infiltrating in breast cancer remain unclear. In this study, we investigated the correlation between VWCE expression and immune infiltration levels in breast cancer. METHODS: The expression of VWCE was analyzed by the tumor immune estimation resource (TIMER) and DriverDB databases. Furthermore, genes co-expressed with VWCE and gene ontology (GO) enrichment analysis were investigated by the STRING and Enrichr web servers. Also, we performed the single nucleotide variation (SNV), copy number variation (CNV), and pathway activity analysis through GSCALite. Subsequently, the relationship between VWCE expression and tumor immunity was analyzed by TIMER and TISIDB databases, and further verified the results using Quantitative Real-Time PCR (RT-PCR), Western blotting, and immunohistochemistry. RESULTS: The results showed that the expression of VWCE mRNA in breast cancer tissue was significantly lower than that in normal tissues. We found that the expression level of VWCE was associated with subtypes, estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor-2 (HER2) status of breast cancerpatients, but there was no significant difference in the expression of VWCE was found in age and nodal status. Further analyses indicated that VWCE was correlated with the activation or inhibition of multiple oncogenic pathways. Additionally, VWCE expression was negatively correlated with the expression of STAT1 (Th1 marker, r = - 0.12, p = 6e-05), but positively correlated with the expression of MS4A4A (r = 0.28, p = 0). These results suggested that the expression of VWCE was correlated with immune infiltration levels of Th1 and M2 macrophage in breast cancer. CONCLUSIONS: In our study, VWCE expression was associated with a better prognosis and was immune infiltration in breast cancer. These findings demonstrate that VWCE is a potential prognostic biomarker and correlated with tumor immune cell infiltration, and maybe a promising therapeutic target in breast cancer.
Entities:
Keywords:
Biomarker; Breast cancer; Tumor-infiltrating; VWCE
Authors: Constantin N Baxevanis; Michael Sofopoulos; Sotirios P Fortis; Sonia A Perez Journal: Cancer Immunol Immunother Date: 2019-03-23 Impact factor: 6.968
Authors: Allen W Zhang; Andrew McPherson; Katy Milne; David R Kroeger; Phineas T Hamilton; Alex Miranda; Tyler Funnell; Nicole Little; Camila P E de Souza; Sonya Laan; Stacey LeDoux; Dawn R Cochrane; Jamie L P Lim; Winnie Yang; Andrew Roth; Maia A Smith; Julie Ho; Kane Tse; Thomas Zeng; Inna Shlafman; Michael R Mayo; Richard Moore; Henrik Failmezger; Andreas Heindl; Yi Kan Wang; Ali Bashashati; Diljot S Grewal; Scott D Brown; Daniel Lai; Adrian N C Wan; Cydney B Nielsen; Curtis Huebner; Basile Tessier-Cloutier; Michael S Anglesio; Alexandre Bouchard-Côté; Yinyin Yuan; Wyeth W Wasserman; C Blake Gilks; Anthony N Karnezis; Samuel Aparicio; Jessica N McAlpine; David G Huntsman; Robert A Holt; Brad H Nelson; Sohrab P Shah Journal: Cell Date: 2018-05-10 Impact factor: 41.582
Authors: Zhaorui Lian; Jie Liu; Li Li; Xianxing Li; N Lale Satiroglu Tufan; Marcy Clayton; Meng-Chao Wu; Hong-Yang Wang; Patrick Arbuthnot; Michael Kew; Mark A Feitelson Journal: Neoplasia Date: 2003 May-Jun Impact factor: 5.715
Authors: Roy M Bremnes; Lill-Tove Busund; Thomas L Kilvær; Sigve Andersen; Elin Richardsen; Erna Elise Paulsen; Sigurd Hald; Mehrdad Rakaee Khanehkenari; Wendy A Cooper; Steven C Kao; Tom Dønnem Journal: J Thorac Oncol Date: 2016-02-01 Impact factor: 15.609